Index of reports
> Cases with Renal Impairment (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kayexalate (Sodium Polystyrene Sulfonate) where reactions include renal impairment. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-14
Patient: 53 year old male
Reactions: Leukocytoclastic Vasculitis, Renal Impairment, Sepsis, Anaemia, Dizziness, Hydrocephalus, Thrombocytopenia, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Administration route: Oral
Start date: 2011-05-01
Keppra
Administration route: Oral
Ramipril
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Repaglinide
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Eupressyl
Administration route: Oral
Start date: 2011-05-29
Prednisolone
Administration route: Oral
Start date: 2011-06-05
End date: 2011-06-26
Calcium Carbonate
Administration route: Oral
Amlodipine Besylate
Administration route: Oral
Prednisolone
Administration route: Oral
Start date: 2011-06-30
Kayexalate
Administration route: Oral
Start date: 2011-06-03
End date: 2011-06-26
Citalopram
Dosage: 20
Administration route: Oral
Renagel
Administration route: Oral
Atorvastatin
Administration route: Oral
Start date: 2011-05-30
End date: 2011-06-24
Aranesp
Dosage: 50mug
Other drugs received by patient: Solu-Medrol; Solu-Medrol
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-06
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis, Renal Impairment, Sepsis, Dizziness, Hydrocephalus, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Citalopram Base
Dosage: unk
Administration route: Oral
Kayexalate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
End date: 2011-06-26
Prednisolone
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Prednisolone
Dosage: unk
Start date: 2011-06-30
Atorvastatin
Dosage: 10 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-24
Eupressyl
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Keppra
Dosage: unk
Administration route: Oral
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Other drugs received by patient: Fucidine CAP; Methylprednisolone; Solu-Medrol; Locoid
Possible Kayexalate side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-03
Patient:
Reactions: Renal Impairment, Anaemia, Sepsis, Hydrocephalus, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Eupressyl
Dosage: 30 mg, tid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Calciparine
Dosage: 0.2 ml, sc
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-08
End date: 2011-08-08
Aranesp
Dosage: 50 mcg, every 15 days
Indication: Product Used FOR Unknown Indication
Kayexalate
Dosage: 15 g, 3x/w
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
Citalopram Hydrobromide
Dosage: 20 mg/kg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Calcium Carbonate
Dosage: 1 unk, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Renagel
Dosage: 1 df, qd
Administration route: Oral
Indication: Hyperphosphataemia
Prednisone TAB
Dosage: 30 mg/kg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-01
Depakene
Dosage: 500 mg/kg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-16
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-02
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis, Renal Impairment, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atorvastatin
Dosage: unk
Administration route: Oral
Start date: 2011-05-30
End date: 2011-06-14
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Eupressyl
Dosage: unk
Administration route: Oral
Start date: 2011-05-29
Keppra
Dosage: unk
Administration route: Oral
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Prednisolone
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Kayexalate
Dosage: unk
Administration route: Oral
Start date: 2011-06-03
End date: 2011-06-26
Citalopram
Dosage: unk
Administration route: Oral
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Other drugs received by patient: Fucidine CAP; Locoid; Solu-Medrol
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-01
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis, Renal Impairment, Sepsis, Dizziness, Hydrocephalus, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kayexalate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
End date: 2011-06-26
Prednisolone
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Prednisolone
Dosage: unk
Start date: 2011-06-30
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Atorvastatin
Dosage: 10 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-24
Eupressyl
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Keppra
Dosage: unk
Administration route: Oral
Citalopram Base
Dosage: unk
Administration route: Oral
Other drugs received by patient: Solu-Medrol; Fucidine CAP; Methylprednisolone; Locoid
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-20
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis, Renal Impairment, Dizziness, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atorvastatin Calcium
Dosage: 10 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-24
Eupressyl
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Prednisolone
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Prednisolone
Dosage: unk
Start date: 2011-06-30
Citalopram Base
Dosage: unk
Administration route: Oral
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Kayexalate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
End date: 2011-06-26
Keppra
Dosage: unk
Administration route: Oral
Other drugs received by patient: Methylprednisolone; Solu-Medrol; Locoid; Fucidine CAP
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-20
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis, Renal Impairment, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atorvastatin Calcium
Dosage: unk
Administration route: Oral
Start date: 2011-05-30
End date: 2011-06-14
Eupressyl
Dosage: unk
Administration route: Oral
Start date: 2011-05-29
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Keppra
Dosage: unk
Administration route: Oral
Kayexalate
Dosage: unk
Administration route: Oral
Start date: 2011-06-03
End date: 2011-06-26
Prednisolone
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Citalopram
Dosage: unk
Administration route: Oral
Other drugs received by patient: Solu-Medrol; Fucidine CAP; Locoid
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-06
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis, Renal Impairment, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Prednisolone
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-04
End date: 2011-06-27
Kayexalate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
End date: 2011-06-26
Ramipril
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-04
End date: 2011-06-14
Citalopram
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Keppra
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Atorvastatin Calcium
Dosage: 10 mg, 1x/day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-24
Eupressyl
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Other drugs received by patient: Methylprednisolone; Fucidine CAP; Locoid
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-01-06
Patient: 53 year old male
Reactions: Renal Impairment, Anaemia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Calcium Carbonate
Dosage: oral
Administration route: Oral
Calciparine
Dosage: subcutaneous
Start date: 2011-07-08
End date: 2011-08-08
Valproate Sodium
Dosage: 1000 mg (1000 mg 1 in 1 d), oral
Administration route: Oral
Start date: 2011-07-16
Prednisone
Dosage: 30 mg (30 mg, 1 in 1 d), oral
Administration route: Oral
Start date: 2011-05-01
Citalopram Hydrobromide
Dosage: oral
Administration route: Oral
Renagel
Dosage: 1 dosage form (1 dosage forms, 1 in 1 d), oral
Administration route: Oral
Eupressyl (Urapidil) (30 Milligram)
Dosage: 90 mg (90 mg, 1 in 1 d), oral
Administration route: Oral
Start date: 2011-05-29
Kayexalate
Dosage: 6.4286 g (45 gm, 1 in 1 wk)
Start date: 2011-06-03
Aranesp
Dosage: 3.3333 microgram (100 mcg, 1 in 1 m)
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-03
Patient: 53 year old male
Reactions: Renal Impairment, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kayexalate
Dosage: unk
Administration route: Oral
Start date: 2011-06-03
End date: 2011-06-26
Eupressyl
Dosage: unk
Administration route: Oral
Start date: 2011-05-29
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Keppra
Dosage: unk
Administration route: Oral
Atorvastatin Calcium
Dosage: 10 mg, 1x/day
Administration route: Oral
Start date: 2011-05-30
End date: 2011-06-24
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Citalopram Hydrobromide
Administration route: Oral
Prednisolone
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Other drugs received by patient: Methylprednisolone
Possible Kayexalate side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-23
Patient: male
Reactions: Renal Impairment, Anaemia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 1 g, qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-16
Prednisone TAB
Dosage: 30 mg/kg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-01
Renagel
Dosage: 1 df, qd
Administration route: Oral
Indication: Hyperphosphataemia
Aranesp
Dosage: 50 mcg, every 15 days
Indication: Product Used FOR Unknown Indication
Citalopram
Dosage: 20 mg/kg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Kayexalate
Dosage: 15 g, 3x/w
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
Eupressyl
Dosage: 30 mg, tid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Calciparine
Dosage: 0.2 ml, qd
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-08
End date: 2011-08-08
Calcium Carbonate
Dosage: 1 unk, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2011-11-18
Patient: 53 year old male
Reactions: Renal Impairment, Anaemia, Condition Aggravated, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kayexalate
Dosage: 6.4286 g (15 gm,3 in 1 wk)
Start date: 2011-06-03
Calcium Carbonate
Dosage: oral
Renagel
Dosage: 1 d f (1 dosage forms,1 in 1 d),oral
Aranesp
Dosage: 3.3333 mcg (50 mcg,1 in 15 d), subcutaneous
Citalopram Hydrobromide
Dosage: 20 mg (20 mg, l in 1 d),oral
Administration route: Oral
Eupressyl (Urapidil)
Dosage: 90 mg (90 rug, 1 in 1 d),oral
Administration route: Oral
Start date: 2011-05-29
Prednisone
Dosage: 1 df (1 dosage forms,1 in 1
Start date: 2011-05-01
Valproate Sodium
Dosage: 1 g (1 gm, 1 in 1 d) , oral
Administration route: Oral
Start date: 2011-07-16
Calciparine
Dosage: subcutaneous
Start date: 2011-07-08
End date: 2011-08-08
Other drugs received by patient: Levetiracetam
|